Ianuarie 2026 – Prezent: Medic specialist oncologie medicală

2024 – 2025: Institut Gustave Roussy, Villejuif, Franța – Intern oncologie medicală, Departamentul DITEP (studii clinice fază I/II)

2024: Institut Gustave Roussy, Villejuif, Franța – Intern oncologie medicală, Thoracic Oncology Group

2021 – 2024: Institutul Oncologic „Prof. Dr. Alexandru Trestioreanu”, București – Medic rezident oncologie medicală

2021 – 2023: Institutul Oncologic „Prof. Dr. Alexandru Trestioreanu”, București – Study Coordinator și Sub-Investigator în studii clinice oncologice fază II/III

2025 – Prezent: Doctorand, Universitatea de Medicină și Farmacie „Carol Davila”, București

2025 – 2026: Certificate of Advanced Studies in Thoracic Malignancies (CAS-TM), European School of Oncology în colaborare cu University of Fribourg, Elveția

2024: Mentorship Programme ESCO – Mentee al Prof. Giuseppe Curigliano

2018 – 2019: Erasmus Externship in Medicine, Université Paris-Sud / Kremlin-Bicêtre / Antoine Béclère / Gustave Roussy, Paris, Franța

2014 – 2020: Doctor Medic, Universitatea de Medicină și Farmacie „Grigore T. Popa”, Iași

2010 – 2014: Colegiul Național „Emil Racoviță”, Iași – Profil Științe ale Naturii

2026

• Forum of Young Oncologists, Romania – speaker şi moderator
• ESMO Lung in Focus Romania
• Actualitǎți în Managementul Cancerelor Mamare
• Simpozionul de Oncologie Translațională Personalizată de Combatere a Cancerului

2025

• Congresul Național de Oncologie SNOMR – speaker
• WCLC Conference – IASLC, Barcelona
• Forum of Young Oncologists, Poiana Brașov – speaker
• European Lung Cancer Congress (ELCC), Paris
• ASCO–AIOM Clinical Research Training for Young Oncologists
• ESMO Targeted Anticancer Therapies Congress, Paris
• Summer School in Immunotherapy, Timișoara

2024

• CONFER Congress, Iași – speaker şi moderator
• ESO Masterclass in Clinical Oncology, San Servolo, Italia
• ESMO Preceptorship on Lung Cancer, Paris
• MAP Congress, Londra
• Refresher Course in Melanoma Surgery, Dublin
• ESMO Advanced Course on ADC Development, Zurich
• ESMO Congress, Barcelona
• ESMO Breast Cancer Congress, Berlin

2023

• CONFER Congress, Iași
• SNOMR Congress, Poiana Brașov
• ESMO Congress, Madrid
• ESMO Advanced Course – NSCLC Oncogene Addicted, Barcelona
• Oncology Academy 2023, Lisabona
• Summer School in Immunotherapy, Timișoara
• IOB Medical and Scientific Days, București
• ESMO Breast Cancer Congress, Berlin
• Forum of Young Oncologists, Sibiu
• European Lung Cancer Congress, Copenhaga
• ESMO Gynaecological Cancers Congress, Barcelona

2022

• ESMO Immuno-Oncology Congress, Geneva
• ESMO Advanced Course – Biomarkers for Precision Medicine, Zurich
• SNOMR Congress, Poiana Brașov
• ESMO Congress, Paris
• ESMO Preceptorship – Breast Cancer, Lugano
• Forum of Young Oncologists, Poiana Brașov

2021

• SNOMR Congress, Poiana Brașov
• Summer School in Immunotherapy, Timișoara
• Forum of Young Oncologists, Poiana Brașov

2020

• Winter School in Immunotherapy, Timișoara

2019

• ESMO Congress, Barcelona
• ESMO-ESO Medical Oncology Course, Valencia

2018

• ESMO Congress, München

2025 – Prezent: Membru RYO – Divizia de mentorat

2025 – Prezent: Societatea Română de Chirurgie Toracică

2025 – Prezent: British Thoracic Oncology Group (BTOG)

2025 – Prezent: International Association for the Study of Lung Cancer (IASLC)

2025 – Prezent: Membru Editorial Board – OncoDaily Medical Journal

2023 – Prezent: Common Sense Oncology (CSO)

2022 – Prezent: American Association for Cancer Research (AACR)

2021 – Prezent: Societatea Națională de Oncologie Medicală din România (SNOMR)

2019 – Prezent: American Society of Clinical Oncology (ASCO)

2018 – Prezent: European Society for Medical Oncology (ESMO)

2017 – Prezent: European School of Oncology (ESO)

• Fellow
• Strategy Working Group

1. Volovat SR, Augustin IG*, Volovat C, Vasilache I, Ostafe M, Panaite DI, et al. Rewriting Tumor Entry Rules: Microfluidic Polyplexes and Tumor-Penetrating Strategies — A Literature Review. Pharmaceutics.2026;18(1):84.
2. Volovat CC, Cosovanu MA, Ostafe MR, Augustin IG*, Volovat C, Georgescu B, Volovat SR. Bacteriophages, Antibiotics and Probiotics: Exploring the Microbial Battlefield of Colorectal Cancer. Int J Mol Sci.2025;26(16):7837. doi:10.3390/ ijms26167837.
3. Popovici IA, Kajanto LA, Popovici LR, Augustin IG*, Gales LN. Navigating Stomatologic Complications Secondary to Antineoplastic Agents — A Comprehensive Review. Cancers (Basel). 2025;17(7):1061. doi:10.3390/cancers17071061. PMID: 40227621.
4. Augustin IG, Constantinescu I. Proven prognostic and predictive micro-RNA signatures in early-stage non-small cell lung cancer. Oncolog-Hematolog. 2025.
5. Augustin IG, Popa E, Kajanto LA. Long-term management of advanced ALK-positive and ROS1-rearranged NSCLC with crizotinib: a case report with recurrent adverse events requiring dose modifications. Oncolog-Hematolog. 2025.
6. Volovat SR, Scripcariu DV, Vasilache IA, Stolniceanu CR, Volovat C, Augustin IG, et al. Oncolytic Virotherapy: A New Paradigm in Cancer Immunotherapy. Int J Mol Sci. 2024;25(2):1180. doi:10.3390/ijms25021180.
7. Burlacu AI, Tanase BC, Augustin I, Cozma GV. Evaluating VATS versus Open Surgery for Non-Small Cell Lung Cancer: A 5-year Retrospective Study. Chirurgia (Bucur). 2024;119(4):393-403. doi:10.21614/chirurgia.2999. PMID: 39250609.
8. Simion L, Augustin IG, Volovat SR, Froicu EM, Schenker M, Mazilu L, et al. HER2 Positive Breast Cancer Therapy — A Challenging and Continuously Moving Pathway. A Narrative Literature Review. Arch Breast Cancer. 2023;10(1):15-25. doi:10.32768/ abc.202310115-25.
9. Zob DL, Augustin I, Caba L, Panzaru MC, Popa S, Popa AD, et al. Genomics and Epigenomics in the Molecular Biology of Melanoma — A Prerequisite for Biomarkers Studies. Int J Mol Sci. 2022;24(1):716. doi:10.3390/ijms24010716. PMID: 36614156.
10. 10.Volovat SR, Augustin I, Zob D, Boboc D, Amurariti F, Volovat C, et al. Use of Personalized Biomarkers in Metastatic Colorectal Cancer and the Impact of AI. Cancers (Basel). 2022;14(19):4834. doi:10.3390/cancers14194834. PMID: 36230757.
11. 11.Pirciu M, Avram E, Augustin IG, Zob D, Lăzescu A. Intratumoral heterogeneity in breast cancer — a real challenge for diagnosis and treatment. Oncolog-Hematolog. 2022;1(58):42.
12. 12.Volovat SR, Negru S, Stolniceanu CR, Volovat C, Lungulescu C, Scripcariu D, Augustin I, et al. Nanomedicine to Modulate Immunotherapy in Cutaneous Melanoma. Exp Ther Med. 2021;21(5):535.
13. 13.Augustin IG, Pirciu M, Stănculeanu DL, Marincaş AM, Radu M, Toma AŞ, et al. A rare case of associated renal, breast and colorectal cancer in a young patient. Oncolog Hematolog. 2021;4(57):33.
14. 14.Volovat SR, Volovat C, Hordila I, Hordila DA, Mirestean CC, Miron OT, Augustin I, et al. MiRNA and LncRNA as Potential Biomarkers in Triple-Negative Breast Cancer: A Review. Front Oncol. 2020;10:526850.
15. 15.Păvăloaia O, Resmeriţă I, Augustin I, Pânzaru M, Martiniuc V, Păduraru L, Gorduza E. Campomelic dysplasia with dextrocardia and without sex-reversal. Arch Clin Cases. 2017;4(1):16-22.
16. 16.Nedelcu AH, Tepordei RT, Augustin I, Partene Vicoleanu S, Mitrea M, Ţăranu T, et al. Uncommon osseous bridge of the atlas identified on cervical spine radiography: Ponticulus posticus — Case series. Rom J Funct Clin Macro Micro Anat Anthropol. 2016;15:387-392.